![James Rolke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Rolke
Chief Executive Officer at
REVELATION BIOSCIENCES, INC.
Net worth: 89 275 $ as of 2026-05-30
Profile
James M.
Rolke is Chief Executive Officer & Director at Revelation Biosciences Sub, Inc. since 2020.
Mr. Rolke is Chairman & Chief Executive Officer at Revelation Biosciences, Inc. starting in 2025.
Mr. Rolke is Director at Revelation Therapeutics LLC.
Former positions include Associate Director-Pharmaceutical Development at Mersana Therapeutics, Inc. from 2006 to 2007, Operations Director at Prospect Therapeutics, Inc. from 2006 to 2009, Associate Scientist at Alpha-Beta Technology, Inc., Chief Scientific Officer at La Jolla Pharmaceutical Co. from 2017 to 2020, Manager-Process Development at Glycogenesys, Inc. from 2003 to 2006, Chief Technology Officer at Pluromed, Inc. from 2009 to 2012, Principal Scientist at Surgical Sealants, Inc., and Scientist at Geltex, Inc. Education includes undergraduate studies at Keene State College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-29 | 81,530 ( 2.09% ) | 89 275 $ | 2026-05-30 |
James Rolke active positions
| Companies | Position | Start |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Chief Executive Officer | 2020-04-30 |
Revelation Therapeutics LLC
 Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Director/Board Member | - |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Chief Executive Officer | 2020-04-30 |
Former positions of James Rolke
| Companies | Position | End |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Tech/Sci/R&D Officer | 2020-05-30 |
Pluromed, Inc.
 Pluromed, Inc. Medical SpecialtiesHealth Technology Manufactures and markets disposable medical devices | Chief Tech/Sci/R&D Officer | 2011-12-31 |
Prospect Therapeutics, Inc.
 Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Corporate Officer/Principal | 2009-04-30 |
| MERSANA THERAPEUTICS | Corporate Officer/Principal | 2006-12-31 |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Corporate Officer/Principal | 2005-12-31 |
Training of James Rolke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Alpha-Beta Technology, Inc.
 Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Discovers, develops and commercialization of novel carbohydrate-based products | Electronic Technology |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in the research and development of pharmaceutical products | Commercial Services |
Pluromed, Inc.
Pluromed, Inc. Medical SpecialtiesHealth Technology Manufactures and markets disposable medical devices | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Keene State College
 Keene State College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Health Technology |
Surgical Sealants, Inc. | |
Revelation Therapeutics LLC
Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Revelation Biosciences Sub, Inc.
Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Revelation Biosciences, Inc.
 Revelation Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics and diagnostics for viral infections | Health Technology |
Geltex, Inc. |
- Stock Market
- Insiders
- James Rolke
